UniProt functional annotation for P00491

UniProt code: P00491.

Organism: Homo sapiens (Human).
Taxonomy: Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
 
Function: Catalyzes the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate (PubMed:9305964, PubMed:23438750). Preferentially acts on 6-oxopurine nucleosides including inosine and guanosine (PubMed:9305964). {ECO:0000269|PubMed:23438750, ECO:0000269|PubMed:9305964}.
 
Catalytic activity: Reaction=inosine + phosphate = alpha-D-ribose 1-phosphate + hypoxanthine; Xref=Rhea:RHEA:27646, ChEBI:CHEBI:17368, ChEBI:CHEBI:17596, ChEBI:CHEBI:43474, ChEBI:CHEBI:57720; EC=2.4.2.1; Evidence={ECO:0000269|PubMed:23438750, ECO:0000269|PubMed:9305964};
Catalytic activity: Reaction=guanosine + phosphate = alpha-D-ribose 1-phosphate + guanine; Xref=Rhea:RHEA:13233, ChEBI:CHEBI:16235, ChEBI:CHEBI:16750, ChEBI:CHEBI:43474, ChEBI:CHEBI:57720; EC=2.4.2.1; Evidence={ECO:0000269|PubMed:9305964};
Catalytic activity: Reaction=2'-deoxyguanosine + phosphate = 2-deoxy-alpha-D-ribose 1- phosphate + guanine; Xref=Rhea:RHEA:27738, ChEBI:CHEBI:16235, ChEBI:CHEBI:17172, ChEBI:CHEBI:43474, ChEBI:CHEBI:57259; EC=2.4.2.1; Evidence={ECO:0000250|UniProtKB:P23492};
Catalytic activity: Reaction=2'-deoxyinosine + phosphate = 2-deoxy-alpha-D-ribose 1- phosphate + hypoxanthine; Xref=Rhea:RHEA:27750, ChEBI:CHEBI:17368, ChEBI:CHEBI:28997, ChEBI:CHEBI:43474, ChEBI:CHEBI:57259; EC=2.4.2.1; Evidence={ECO:0000250|UniProtKB:P23492};
Activity regulation: Inhibited by 5'-deaza-1'-aza-2c-deoxy-1'-(9- methylene)-Immucilin-G (DADMe-ImmG). {ECO:0000269|PubMed:23438750}.
Biophysicochemical properties: Kinetic parameters: KM=45 uM for inosine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; KM=68 uM for inosine (at 25 degrees Celsius and pH 7.4) {ECO:0000269|PubMed:23438750}; KM=10 uM for hypoxanthine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; KM=6 uM for guanosine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; KM=12 uM for guanine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; KM=650 uM for adenosine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; KM=440 uM for adenine (at 30 degrees Celsius and pH 7) {ECO:0000269|PubMed:9305964}; Note=kcat is 57 sec(-1) with inosine as substrate (PubMed:9305964). kcat is 47 sec(-1) with inosine as substrate (PubMed:23438750). kcat is 70 sec(-1) with hypoxanthine as substrate (PubMed:9305964). kcat is 28 sec(-1) with guanosine as substrate (PubMed:9305964). kcat is 48 sec(-1) with guanine as substrate (PubMed:9305964). kcat is 0.0024 sec(-1) with adenosine as substrate (PubMed:9305964). kcat is 0.31 sec(-1) with adenine as substrate (PubMed:9305964). {ECO:0000269|PubMed:23438750, ECO:0000269|PubMed:9305964};
Pathway: Purine metabolism; purine nucleoside salvage. {ECO:0000269|PubMed:9305964}.
Subunit: Homotrimer. {ECO:0000305|PubMed:23438750}.
Subcellular location: Cytoplasm {ECO:0000269|PubMed:22509282}.
Tissue specificity: Expressed in red blood cells; overexpressed in red blood cells (cytoplasm) of patients with hereditary non-spherocytic hemolytic anemia of unknown etiology. {ECO:0000269|PubMed:22509282}.
Disease: Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179]: A disorder that interrupts both the catabolism of inosine into hypoxanthine and guanosine into guanine, and leads to the accumulation of guanosine, inosine, and their deoxified by-products. The main clinical presentation is recurrent infections due to severe T- cell immunodeficiency. Some patients also have neurologic impairment. {ECO:0000269|PubMed:1384322, ECO:0000269|PubMed:3029074, ECO:0000269|PubMed:8931706}. Note=The disease is caused by variants affecting the gene represented in this entry.
Similarity: Belongs to the PNP/MTAP phosphorylase family. {ECO:0000305}.

Annotations taken from UniProtKB at the EBI.